Open AccessClinicopathological characteristics and treatment outcomes of luminal B1 breast cancer in Taiwan
Author(s) -
Bo-Fang Chen,
YiFang Tsai,
ChiCheng Huang,
ChihYi Hsu,
PeiJu Lien,
Yuling Wang,
YuanYung Lin,
Chin-Jung Feng,
KuangLiang King,
JenHwey Chiu,
GarYang Chau,
LingMing Tseng
Publication year - 2022
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000632
Subject(s) - medicine , oncology , breast cancer , cancer , gynecology
Hormone receptor-positive, human epidermal growth factor receptor II (HER2)-negative luminal B1 breast cancer is associated with a higher risk of disease relapse than luminal A breast cancer. Therefore, we assessed and compared the distant metastasis pattern and clinical outcomes associated with luminal B1 and luminal A breast cancer in an Asian population.